MYC and the control of DNA replication

Cold Spring Harbor Perspectives in Medicine

Volumn 4, Issue 6, 2014, Pages

  Dominguez Sola, David ^a,b   Gautier, Jean ^a  

^a Howard Hughes Medical Institute   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; BRCA1 PROTEIN; CDC45 PROTEIN; CELL CYCLE PROTEIN 6; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE 2; CYCLIN E; HISTONE H2AX; MINICHROMOSOME MAINTENANCE PROTEIN 2; MYC PROTEIN; NUCLEOTIDE; ORC1 PROTEIN; PROTEIN P53; REPLICATION LICENSING FACTOR CDT1; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; WERNER SYNDROME PROTEIN; MYC PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CHROMOSOME REPLICATION; DNA DAMAGE; DNA REPLICATION; DNA REPLICATION TIMING; DNA STRUCTURE; DNA SYNTHESIS; ENZYME ACTIVITY; GENE REARRANGEMENT; GENOMIC INSTABILITY; HUMAN; NEOPLASM; NONHUMAN; ONCOGENE SRC; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

CELL TRANSFORMATION, NEOPLASTIC; DNA REPLICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR MARKERS, BIOLOGICAL;

EID: 84891752437     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a014423     Document Type: Article

References (202)

1. Aggarwal BD, Calvi BR. 2004. Chromatin regulates origin activity in Drosophila follicle cells. Nature 430: 372-376.
2. Alexandrov LB, Nik-Zainal S, Wedge DC, Campbell PJ, Stratton MR. 2013a. Deciphering signatures of mutational processes operative in human cancer. Cell Rep 3: 246-259.
3. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, et al. 2013b. Signatures of mutational processes in human cancer. Nature 500: 415-421.
4. Alles MC, Gardiner-Garden M, Nott DJ, Wang Y, Foekens JA, Sutherland RL, Musgrove EA, Ormandy CJ. 2009. Meta-analysis and gene set enrichment relative to ER status reveal elevated activity of MYC and E2F in the “basal” breast cancer subgroup. PloS ONE 4: e4710.
5. Amati B, Alevizopoulos K, Vlach J. 1998. Myc and the cell cycle. Front Biosci 3: d250-d268.
6. Arlt MF, Mulle JG, Schaibley VM, Ragland RL, Durkin SG, Warren ST, Glover TW. 2009. Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants. Am J Hum Genet 84: 339-350.
7. Arlt MF, Ozdemir AC, Birkeland SR, Wilson TE, Glover TW. 2011. Hydroxyurea induces de novo copy number variants in human cells. Proc Natl Acad Sci 108: 17360-17365.
8. Artandi SE, DePinho RA. 2010. Telomeres and telomerase in cancer. Carcinogenesis 31: 9-18.
9. Azvolinsky A, Giresi PG, Lieb JD, Zakian VA. 2009. Highly transcribed RNA polymerase II genes are impediments to replication fork progression in Saccharomyces cerevisiae. Mol Cell 34: 722-734.
10. Barlow JH, Faryabi RB, Callen E, Wong N, Malhowski A, Chen HT, Gutierrez-Cruz G, Sun HW, McKinnon P, Wright G, et al. 2013. Identification of early replicating fragile sites that contribute to genome instability. Cell 152: 620-632.
11. Bartek J, Bartkova J, Lukas J. 2007. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26: 7773-7779.
12. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, et al. 2005. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864-870.
13. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, et al. 2006. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637.
14. Bell SP, Dutta A. 2002. DNA replication in eukaryotic cells. Ann Rev Biochem 71: 333-374.
15. Bermejo R, Lai MS, Foiani M. 2012. Preventing replication stress to maintain genome stability: Resolving conflicts between replication and transcription. Mol Cell 45: 710-718.
16. Berns K, Hijmans EM, Bernards R. 1997. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene 15: 1347-1356.
17. Bester AC, Roniger M, Oren YS, Im MM, Sarni D, Chaoat M, Bensimon A, Zamir G, Shewach DS, Kerem B. 2011. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145: 435-446.
18. Black JC, Manning AL, Van Rechem C, Kim J, Ladd B, Cho J, Pineda CM, Murphy N, Daniels DL, Montagna C, et al. 2013. KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors. Cell 154: 541-555.
19. Blow JJ, Dutta A. 2005. Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol 6: 476-486.
20. Boos D, Sanchez-Pulido L, Rappas M, Pearl LH, Oliver AW, Ponting CP, Diffley JF. 2011. Regulation of DNA replication through Sld3-Dpb11 interaction is conserved from yeast to humans. Curr Biol 21: 1152-1157.
21. Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M, Luscher B. 2001. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 15: 2042-2047.
22. Branzei D, Foiani M. 2010. Maintaining genome stability at the replication fork. Nat Rev Mol Cell Biol 11: 208-219.
23. Burrell RA, McClelland SE, Endesfelder D, Groth P, Weller MC, Shaikh N, Domingo E, Kanu N, Dewhurst SM, Gronroos E, et al. 2013. Replication stress links structural and numerical cancer chromosomal instability. Nature 494: 492-496.
24. Cadoret JC, Meisch F, Hassan-Zadeh V, Luyten I, Guillet C, Duret L, Quesneville H, Prioleau MN. 2008. Genomewide studies highlight indirect links between human replication origins and gene regulation. Proc Natl Acad Sci 105: 15837-15842.
25. Calado DP, Sasaki Y, Godinho SA, Pellerin A, Kochert K, Sleckman BP, de Alboran IM, Janz M, Rodig S, Rajewsky K. 2012. The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers. Nat Immunol 13: 1092-1100.
26. Campaner S, Doni M, Hydbring P, Verrecchia A, Bianchi L, Sardella D, Schleker T, Perna D, Tronnersjo S, Murga M, et al. 2010. Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nat Cell Biol 12: 54-59.
27. Campbell KJ, White RJ. 2014. MYC regulation of cell growth through control of transcription by RNA polymerases I and III. Cold Spring Harb Perspect Med 4: a018408.
28. Carr AM, Paek AL, Weinert T. 2011. DNA replication: Failures and inverted fusions. Semin Cell Dev Biol 22: 866-874.
29. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S. 2005. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132: 885-896.
30. Casper AM, Nghiem P, Arlt MF, Glover TW. 2002. ATR regulates fragile site stability. Cell 111: 779-789.
31. Cimprich KA, Cortez D. 2008. ATR: An essential regulator of genome integrity. Nat Rev Mol Cell Biol 9: 616-627.
32. Cohen SM, Brylawski BP, Cordeiro-Stone M, Kaufman DG. 2003. Same origins of DNA replication function on the active and inactive human X chromosomes. J Cell Biochem 88: 923-931.
33. Cornacchia D, Dileep V, Quivy JP, Foti R, Tili F, Santarella-Mellwig R, Antony C, Almouzni G, Gilbert DM, Buonomo SB. 2012. Mouse Rif1 is a key regulator of the replication-timing programme in mammalian cells. EMBO J 31: 3678-3690.
34. Costa A, Ilves I, Tamberg N, Petojevic T, Nogales E, Botchan MR, Berger JM. 2011. The structural basis for MCM2-7 h elicase activation by GINS and Cdc45. Nat Struct Mol Biol 18: 471-477.
35. Costa A, Hood IV, Berger JM. 2013. Mechanisms for initiating cellular DNA replication. Annu Rev Biochem 82: 25-54.
36. Couch FB, Bansbach CE, Driscoll R, Luzwick JW, Glick GG, Betous R, Carroll CM, Jung SY, Qin J, Cimprich KA, et al. 2013. ATR phosphorylates SMARCAL1 to prevent replication fork collapse. Genes Dev 27: 1610-1623.
37. D’Adda di Fagagna F. 2008. Living on a break: Cellular senescence as a DNA-damage response. Nat Rev Cancer 8: 512-522.
38. Dang CV. 2013. MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med 3: a014217.
39. Danis E, Brodolin K, Menut S, Maiorano D, Girard-Reydet C, Mechali M. 2004. Specification of a DNA replication origin by a transcription complex. Nat Cell Biol 6: 721-730.
40. de Alboran IM, O’Hagan RC, Gartner F, Malynn B, Davidson L, Rickert R, Rajewsky K, DePinho RA, Alt FW. 2001. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14: 45-55.
41. Deb-Basu D, Aleem E, Kaldis P, Felsher DW. 2006. CDK2 is required by MYC to induce apoptosis. Cell Cycle 5: 1342-1347.
42. Dellino GI, Cittaro D, Piccioni R, Luzi L, Banfi S, Segalla S, Cesaroni M, Mendoza-Maldonado R, Giacca M, Pelicci PG. 2013. Genome-wide mapping of human DNA-replication origins: Levels of transcription at ORC1 sites regulate origin selection and replication timing. Genome Res 23: 1-11.
43. DePamphilis ML, Blow JJ, Ghosh S, Saha T, Noguchi K, Vassilev A. 2006. Regulating the licensing of DNA replication origins in metazoa. Curr Opin Cell Biol 18: 231-239.
44. Dereli-Oz A, Versini G, Halazonetis TD. 2011. Studies of genomic copy number changes in human cancers reveal signatures of DNA replication stress. Mol Oncol 5: 308-314.
45. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre M, Nuciforo PG, Bensimon A, et al. 2006. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-642.
46. Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J, Dalla-Favera R. 2007. Non-transcriptional control of DNA replication by c-Myc. Nature 448: 445-451.
47. Dominguez-Sola D, Victora GD, Ying CY, Phan RT, Saito M, Nussenzweig MC, Dalla-Favera R. 2012. The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry. Nat Immunol 13: 1083-1091.
48. Durkin SG, Glover TW. 2007. Chromosome fragile sites. Ann Rev Genet 41: 169-192.
49. Eilers M, Schirm S, Bishop JM. 1991. The MYC protein activates transcription of the a-prothymosin gene. EMBO J 10: 133-141.
50. Enomoto T. 2001. Functions of RecQ family helicases: Possible involvement of Bloom’s and Werner’s syndrome gene products in guarding genome integrity during DNA replication. J Biochem 129: 501-507.
51. Errico A, Costanzo V. 2010. Differences in the DNA replication of unicellular eukaryotes and metazoans: Known unknowns. EMBO Rep 11: 270-278.
52. Evertts AG, Coller HA. 2012. Back to the origin: Reconsidering replication, transcription, epigenetics, and cell cycle control. Genes Cancer 3: 678-696.
53. Fang H, Nie L, Chi Z, Liu J, Guo D, Lu X, Hei TK, Balajee AS, Zhao Y. 2013. RecQL4 helicase amplification is involved in human breast tumorigenesis. PloS ONE 8: e69600.
54. Felsher DW, Bishop JM. 1999. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc Natl Acad Sci 96: 3940-3944.
55. Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A, Amati B. 2003. Genomic targets of the human c-Myc protein. Genes Dev 17: 1115-1129.
56. Fest T, Mougey V, Dalstein V, Hagerty M, Milette D, Silva S, Mai S. 2002. c-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis. Oncogene 21: 2981-2990.
57. Franchitto A, Pirzio LM, Prosperi E, Sapora O, Bignami M, Pichierri P. 2008. Replication fork stalling in WRN-deficient cells is overcome by prompt activation of a MUS81dependent pathway. J Cell Biol 183: 241-252.
58. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B. 2001. Binding of c-Myc to chromatin mediates mitogeninduced acetylation of histone H4 and gene activation. Genes Dev 15: 2069-2082.
59. Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM, Livingston DM, Amati B. 2003. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 4: 575-580.
60. Furstenthal L, Swanson C, Kaiser BK, Eldridge AG, Jackson PK. 2001. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication. Nat Cell Biol 3: 715-722.
61. Gabay M, Li Y, Felsher DW. 2014. MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb Perspect Med. doi: 10.1101/cshperspect.a014241.
62. Gilbert DM. 2010. Cell fate transitions and the replication timing decision point. J Cell Biol 191: 899-903.
63. Glover TW. 2006. Common fragile sites. Cancer Lett 232: 4-12.
64. Gomez-Roman N, Grandori C, Eisenman RN, White RJ. 2003. Direct activation of RNA polymerase III transcription by c-Myc. Nature 421: 290-294.
65. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr, Kastrinakis NG, Levy B, et al. 2005. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907-913.
66. Gorrini C, Squatrito M, Luise C, Syed N, Perna D, Wark L, Martinato F, Sardella D, Verrecchia A, Bennett S, et al. 2007. Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature 448: 1063-1067.
67. Grandori C, Wu KJ, Fernandez P, Ngouenet C, Grim J, Clurman BE, Moser MJ, Oshima J, Russell DW, Swisshelm K, et al. 2003. Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev 17: 1569-1574.
68. Grandori C, Robinson KL, Galloway DA, Swisshelm K. 2004. Functional link between Myc and the Werner gene in tumorigenesis. Cell Cycle 3: 22-25.
69. Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, White RJ. 2005. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 7: 311-318.
70. Green BM, Finn KJ, Li JJ. 2010. Loss of DNA replication control is a potent inducer of gene amplification. Science 329: 943-946.
71. Gutierrez C, Guo ZS, Farrell-Towt J, Ju G, DePamphilis ML. 1987. c-myc protein and DNA replication: Separation of c-myc antibodies from an inhibitor of DNA synthesis. Mol Cell Biol 7: 4594-4598.
72. Gutierrez C, Guo ZS, Burhans W, DePamphilis ML, Farrell-Towt J, Ju G. 1988. Is c-myc protein directly involved in DNA replication? Science 240: 1202-1203.
73. Halazonetis TD, Gorgoulis VG, Bartek J. 2008. An oncogene-induced DNA damage model for cancer development. Science 319: 1352-1355.
74. Hartwell LH, Kastan MB. 1994. Cell cycle control and cancer. Science 266: 1821-1828.
75. Hayano M, Kanoh Y, Matsumoto S, Renard-Guillet C, Shirahige K, Masai H. 2012. Rif1 is a global regulator of timing of replication origin firing in fission yeast. Genes Dev 26: 137-150.
76. Hermeking H, Wolf DA, Kohlhuber F, Dickmanns A, Billaud M, Fanning E, Eick D. 1994. Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. Proc Natl Acad Sci 91: 10412-10416.
77. Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ, O’Connell BC, Mateyak MK, Tam W, Kohlhuber F, et al. 2000. Identification of CDK4 as a target of c-MYC. Proc Natl Acad Sci 97: 2229-2234.
78. Herold S, Wanzel M, Beuger V, Frohme C, Beul D, Hillukkala T, Syvaoja J, Saluz HP, Haenel F, Eilers M. 2002. Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol Cell 10: 509-521.
79. Herold S, Hock A, Herkert B, Berns K, Mullenders J, Beijersbergen R, Bernards R, Eilers M. 2008. Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1. EMBO J 27: 2851-2861.
80. Holzel M, Kohlhuber F, Schlosser I, Holzel D, Luscher B, Eick D. 2001. Myc/Max/Mad regulate the frequency but not the duration of productive cell cycles. EMBO Rep 2: 1125-1132.
81. Huvet M, Nicolay S, Touchon M, Audit B, d’Aubenton-Carafa Y, Arneodo A, Thermes C. 2007. Human gene organization driven by the coordination of replication and transcription. Genome Res 17: 1278-1285.
82. Hydbring P, Bahram F, Su Y, Tronnersjo S, Hogstrand K, von der Lehr N, Sharifi HR, Lilischkis R, Hein N, Wu S, et al. 2010. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation. Proc Natl Acad Sci 107: 58-63.
83. Ichijima Y, Yoshioka K, Yoshioka Y, Shinohe K, Fujimori H, Unno J, Takagi M, Goto H, Inagaki M, Mizutani S, et al. 2010. DNA lesions induced by replication stress trigger mitotic aberration and tetraploidy development. PloS ONE 5: e8821.
84. Iguchi-Ariga SM, Itani T, Kiji Y, Ariga H. 1987. Possible function of the c-myc product: Promotion of cellular DNA replication. EMBO J 6: 2365-2371.
85. Iguchi-Ariga SM, Okazaki T, Itani T, Ogata M, Sato Y, Ariga H. 1988. An initiation site of DNA replication with transcriptional enhancer activity present upstream of the cmyc gene. EMBO J 7: 3135-3142.
86. Ikura T, Ogryzko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, Scully R, Qin J, Nakatani Y. 2000. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 102: 463-473.
87. Kaczmarek L, Hyland JK, Watt R, Rosenberg M, Baserga R. 1985. Microinjected c-myc as a competence factor. Science 228: 1313-1315.
88. Karnani N, Taylor CM, Malhotra A, Dutta A. 2010. Genomic study of replication initiation in human chromosomes reveals the influence of transcription regulation and chromatin structure on origin selection. Mol Biol Cell 21: 393-404.
89. Kennedy RD, Gorski JJ, Quinn JE, Stewart GE, James CR, Moore S, Mulligan K, Emberley ED, Lioe TF, Morrison PJ, et al. 2005. BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene. Cancer Res 65: 10265-10272.
90. Knoepfler PS, Cheng PF, Eisenman RN. 2002. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev 16: 2699-2712.
91. Knoepfler PS, Zhang XY, Cheng PF, Gafken PR, McMahon SB, Eisenman RN. 2006. Myc influences global chromatin structure. EMBO J 25: 2723-2734.
92. Knott SR, Viggiani CJ, Tavare S, Aparicio OM. 2009. Genome-wide replication profiles indicate an expansive role for Rpd3L in regulating replication initiation timing or efficiency, and reveal genomic loci of Rpd3 function in Saccharomyces cerevisiae. Genes Dev 23: 1077-1090.
93. Knott SR, Peace JM, Ostrow AZ, Gan Y, Rex AE, Viggiani CJ, Tavare S, Aparicio OM. 2012. Forkhead transcription factors establish origin timing and long-range clustering in S. cerevisiae. Cell 148: 99-111.
94. Koch HB, Zhang R, Verdoodt B, Bailey A, Zhang CD, Yates JR 3rd, Menssen A, Hermeking H. 2007. Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. Cell Cycle 6: 205-217.
95. Kohzaki H, Murakami Y. 2005. Transcription factors and DNA replication origin selection. BioEssays 27: 1107-1116.
96. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. 2010. The essence of senescence. Genes Dev 24: 2463-2479.
97. Kumagai A, Lee J, Yoo HY, Dunphy WG. 2006. TopBP1 activates the ATR-ATRIP complex. Cell 124: 943-955.
98. Kumagai A, Shevchenko A, Shevchenko A, Dunphy WG. 2010. Treslin collaborates with TopBP1 in triggering the initiation of DNA replication. Cell 140: 349-359.
99. Kumagai A, Shevchenko A, Shevchenko A, DUnphy WG. 2011. Direct regulation of Treslin by cyclin-dependent kinase is essential for the onset of DNA replication. J Cell Biol 193: 995-1007.
100. Kumar A, Marques M, Carrera AC. 2006. Phosphoinositide 3-kinase activation in late G1 is required for c-Myc stabilization and S-phase entry. Mol Cell Biol 26: 9116-9125.
101. Kuttler F, Mai S. 2006. c-Myc, genomic instability and disease. Genome Dyn 1: 171-190.
102. Kuzyk A, Mai S. 2014. c-MYC-induced genomic instability. Cold Spring Harb Perspect Med 4: a014373.
103. Laurenti E, Varnum-Finney B, Wilson A, Ferrero I, Blanco-Bose WE, Ehninger A, Knoepfler PS, Cheng PF, MacDonald HR, Eisenman RN, et al. 2008. Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Cell Stem Cell 3: 611-624.
104. Lee JA, Carvalho CM, Lupski JR. 2007. A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 131: 1235-1247.
105. Lemaitre JM, Bocquet S, Buckle R, Mechali M. 1995. Selective and rapid nuclear translocation of a c-Myc-containing complex after fertilization of Xenopus laevis eggs. Mol Cell Biol 15: 5054-5062.
106. Leon J, Ferrandiz N, Acosta JC, Delgado MD. 2009. Inhibition of cell differentiation: A critical mechanism for MYC-mediated carcinogenesis? Cell Cycle 8: 1148-1157.
107. Letessier A, Millot GA, Koundrioukoff S, Lachages AM, Vogt N, Hansen RS, Malfoy B, Brison O, Debatisse M. 2011. Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature 470: 120-123.
108. Li H, Lee TH, Avraham H. 2002. A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer. J Biol Chem 277: 20965-20973.
109. Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI, Young RA. 2012. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151: 56-67.
110. Liu YC, Li F, Handler J, Huang CR, Xiang Y, Neretti N, Sedivy JM, Zeller KI, Dang CV. 2008. Global regulation of nucleotide biosynthetic genes by c-Myc. PloS ONE 3: e2722.
111. MacAlpine DM, Rodriguez HK, Bell SP. 2004. Coordination of replication and transcription along a Drosophila chromosome. Genes Dev 18: 3094-3105.
112. Maclean KH, Kastan MB, Cleveland JL. 2007. Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis. Mol Cancer Res 5: 705-711.
113. Mannava S, Grachtchouk V, Wheeler LJ, Im M, Zhuang D, Slavina EG, Mathews CK, Shewach DS, Nikiforov MA. 2008. Direct role of nucleotide metabolism in C-MYCdependent proliferation of melanoma cells. Cell Cycle 7: 2392-2400.
114. Mantiero D, Mackenzie A, Donaldson A, Zegerman P. 2011. Limiting replication initiation factors execute the temporal programme of origin firing in budding yeast. EMBO J 30: 4805-4814.
115. Marques M, Kumar A, Cortes I, Gonzalez-Garcia A, Hernandez C, Moreno-Ortiz MC, Carrera AC. 2008. Phosphoinositide 3-kinases p110a and p110b regulate cell cycle entry, exhibiting distinct activation kinetics in G1 phase. Mol Cell Biol 28: 2803-2814.
116. Martinato F, Cesaroni M, Amati B, Guccione E. 2008. Analysis of Myc-induced histone modifications on target chromatin. PloS ONE 3: e3650.
117. Mateyak MK, Obaya AJ, Adachi S, Sedivy JM. 1997. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 8: 1039-1048.
118. Mechali M. 2010. Eukaryotic DNA replication origins: Many choices for appropriate answers. Nat Rev Mol Cell Biol 11: 728-738.
119. Menssen A, Epanchintsev A, Lodygin D, Rezaei N, Jung P, Verdoodt B, Diebold J, Hermeking H. 2007. c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1: Identification of mechanisms underlying c-MYC-induced DNA damage and chromosomal instability. Cell Cycle 6: 339-352.
120. Mesner LD, Crawford EL, Hamlin JL. 2006. Isolating apparently pure libraries of replication origins from complex genomes. Mol cell 21: 719-726.
121. Michor F, Iwasa Y, Vogelstein B, Lengauer C, Nowak MA. 2005. Can chromosomal instability initiate tumorigenesis? Semin Cancer Biol 15: 43-49.
122. Miotto B, Struhl K. 2010. HBO1 histone acetylase activity is essential for DNA replication licensing and inhibited by Geminin. Mol Cell 37: 57-66.
123. Morrish F, Hockenbery D. 2014. MYC and mitochondrial biogenesis. Cold Spring Harb Perspect Med 4: a014225.
124. Morrish F, Neretti N, Sedivy JM, Hockenbery DM. 2008. The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry. Cell Cycle 7: 1054-1066.
125. Moser R, Toyoshima M, Robinson K, Gurley KE, Howie HL, Davison J, Morgan M, Kemp CJ, Grandori C. 2012. MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency. Mol Cancer Res 10: 535-545.
126. Mueller AC, Keaton MA, Dutta A. 2011. DNA replication: Mammalian Treslin-TopBP1 interaction mirrors yeast Sld3-Dpb11. Curr Biol 21: R638-R640.
127. Muller D, Bouchard C, Rudolph B, Steiner P, Stuckmann I, Saffrich R, Ansorge W, Huttner W, Eilers M. 1997. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene 15: 2561-2576.
128. Muncan V, Sansom OJ, Tertoolen L, Phesse TJ, Begthel H, Sancho E, Cole AM, Gregorieff A, de Alboran IM, Clevers H, et al. 2006. Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc. Mol Cell Biol 26: 8418-8426.
129. Murfuni I, Nicolai S, Baldari S, Crescenzi M, Bignami M, Franchitto A, Pichierri P. 2013. The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation. Oncogene 32: 610-620.
130. Murga M, Campaner S, Lopez-Contreras AJ, Toledo LI, Soria R, Montana MF, D’Artista L, Schleker T, Guerra C, Garcia E, et al. 2011. Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nat Struct Mol Biol 18: 1331-1335.
131. Necsulea A, Guillet C, Cadoret JC, Prioleau MN, Duret L. 2009. The relationship between DNA replication and human genome organization. Mol Biol Evol 26: 729-741.
132. Neelsen KJ, Zanini IM, Herrador R, Lopes M. 2013. Oncogenes induce genotoxic stress by mitotic processing of unusual replication intermediates. J Cell Biol 200: 699-708.
133. Negrini S, Gorgoulis VG, Halazonetis TD. 2010. Genomic instability—An evolving hallmark of cancer. Nat Rev Mol Cell Biol 11: 220-228.
134. Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, et al. 2012. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151: 68-79.
135. Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih Ie M, Vogelstein B, Lengauer C. 2002. The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci 99: 16226-16231.
136. Obaya AJ, Mateyak MK, Sedivy JM. 1999. Mysterious liaisons: The relationship between c-Myc and the cell cycle. Oncogene 18: 2934-2941.
137. Obaya AJ, Kotenko I, Cole MD, Sedivy JM. 2002. The protooncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 to facilitate the activation of Cdk4/6 and early G1 phase progression. J Biol Chem 277: 31263-31269.
138. O’Connell BC, Cheung AF, Simkevich CP, Tam W, Ren X, Mateyak MK, Sedivy JM. 2003. A large scale genetic analysis of c-Myc-regulated gene expression patterns. J Biol Chem 278: 12563-12573.
139. O’Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA, Goodship JA. 2003. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat Genet 33: 497-501.
140. O’Hagan RC, Ohh M, David G, de Alboran IM, Alt FW, Kaelin WG Jr, DePinho RA. 2000. Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression. Genes Dev 14: 2185-2191.
141. Orian A, van Steensel B, Delrow J, Bussemaker HJ, Li L, Sawado T, Williams E, Loo LW, Cowley SM, Yost C, et al. 2003. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev 17: 1101-1114.
142. Pacek M, Tutter AV, Kubota Y, Takisawa H, Walter JC. 2006. Localization of MCM2-7,Cdc45, and GINS to the site of DNA unwinding during eukaryotic DNA replication. Mol Cell 21: 581-587.
143. Perez-Roger I, Solomon DL, Sewing A, Land H. 1997. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes. Oncogene 14: 2373-2381.
144. Pichierri P, Ammazzalorso F, Bignami M, Franchitto A. 2011. The Werner syndrome protein: Linking the replication checkpoint response to genome stability. Aging 3: 311-318.
145. Pierce SB, Yost C, Anderson SA, Flynn EM, Delrow J, Eisenman RN. 2008. Drosophila growth and development in the absence of dMyc and dMnt. Dev Biol 315: 303-316.
146. Pleasance ED, Stephens PJ, O’Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, et al. 2010. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463: 184-190.
147. Poe JC, Minard-Colin V, Kountikov EI, Haas KM, Tedder TF. 2012. A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice. J Immunol 189: 2318-2325.
148. Poli J, Tsaponina O, Crabbe L, Keszthelyi A, Pantesco V, Chabes A, Lengronne A, Pasero P. 2012. dNTP pools determine fork progression and origin usage under replication stress. EMBO J 31: 883-894.
149. Pomerantz RT, O’Donnell M. 2008. The replisome uses mRNA as a primer after colliding with RNA polymerase. Nature 456: 762-766.
150. Prathapam T, Tegen S, Oskarsson T, Trumpp A, Martin GS. 2006. Activated Src abrogates the Myc requirement for the G0/G1 transition but not for the G1/S transition. Proc Natl Acad Sci 103: 2695-2700.
151. Prochownik EV. 2008. c-Myc: Linking transformation and genomic instability. Curr Mol Med 8: 446-458.
152. Pryde F, Jain D, Kerr A, Curley R, Mariotti FR, Vogelauer M. 2009. H3 k36 methylation helps determine the timing of cdc45 association with replication origins. PloS ONE 4: e5882.
153. Pusapati RV, Rounbehler RJ, Hong S, Powers JT, Yan M, Kiguchi K, McArthur MJ, Wong PK, Johnson DG. 2006. ATM promotes apoptosis and suppresses tumorigenesis in response to Myc. Proc Natl Acad Sci 103: 1446-1451.
154. Pusch O, Bernaschek G, Eilers M, Hengstschlager M. 1997. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases. Oncogene 15: 649-656.
155. Reimann M, Loddenkemper C, Rudolph C, Schildhauer I, Teichmann B, Stein H, Schlegelberger B, Dorken B, Schmitt CA. 2007. The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo. Blood 110: 2996-3004.
156. Ren J, Jin F, Yu Z, Zhao L, Wang L, Bai X, Zhao H, Yao W, Mi X, Wang E, et al. 2013. MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency. Tumour Biol 34: 3945-3958.
157. Robinson K, Asawachaicharn N, Galloway DA, Grandori C. 2009. c-Myc accelerates S phase and requires WRN to avoid replication stress. PloS ONE 4: e5951.
158. Rosales T, Nie Z, Kapoor V, Casellas R Jr, Knutson JR, Levens D. 2013. Partition of Myc into immobile vs. mobile complexes within nuclei. Sci Rep 3: 1953.
159. Ryba T, Hiratani I, Sasaki T, Battaglia D, Kulik M, Zhang J, Dalton S, Gilbert DM. 2011. Replication timing: A fingerprint for cell identity and pluripotency. PLoS Comput Biol 7: e1002225.
160. Sankar N, Kadeppagari RK, Thimmapaya B. 2009. c-Mycinduced aberrant DNA synthesis and activation of DNA damage response in p300 knockdown cells. J Biol Chem 284: 15193-15205.
161. Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR, Vass JK, Athineos D, Clevers H, Clarke AR. 2007. Myc deletion rescues Apc deficiency in the small intestine. Nature 446: 676-679.
162. Sasaki T, Ramanathan S, Okuno Y, Kumagai C, Shaikh SS, Gilbert DM. 2006. The Chinese hamster dihydrofolate reductase replication origin decision point follows activation of transcription and suppresses initiation of replication within transcription units. Mol Cell Biol 26: 1051-1062.
163. Schorl C, Sedivy JM. 2003. Loss of protooncogene c-Myc function impedes G1 phase progression both before and after the restriction point. Mol Biol Cell 14: 823-835.
164. Schvartzman JM, Sotillo R, Benezra R. 2010. Mitotic chromosomal instability and cancer: Mouse modelling of the human disease. Nat Rev Cancer 10: 102-115.
165. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. 2000. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 14: 2501-2514.
166. Segurado M, Tercero JA. 2009. The S-phase checkpoint: Targeting the replication fork. Biol Cell 101: 617-627.
167. Seoane J, Le HV, Massague J. 2002. Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419: 729-734.
168. Sequeira-Mendes J, Diaz-Uriarte R, Apedaile A, Huntley D, Brockdorff N, Gomez M. 2009. Transcription initiation activity sets replication origin efficiency in mammalian cells. PLoS Genet 5: e1000446.
169. Shechter D, Gautier J. 2005. ATM and ATR check in on origins: A dynamic model for origin selection and activation. Cell Cycle 4: 235-238.
170. Shechter D, Costanzo V, Gautier J. 2004. ATR and ATM regulate the timing of DNA replication origin firing. Nat Cell Biol 6: 648-655.
171. Sherr CJ, Roberts JM. 2004. Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18: 2699-2711.
172. Shichiri M, Hanson KD, Sedivy JM. 1993. Effects of c-myc expression on proliferation, quiescence, and the G0 to G1 transition in nontransformed cells. Cell Growth Differ 4: 93-104.
173. Shreeram S, Hee WK, Demidov ON, Kek C, Yamaguchi H, Fornace AJ Jr, Anderson CW, Appella E, Bulavin DV. 2006. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase. J Exp Med 203: 2793-2799.
174. Sidorova JM. 2008. Roles of the Werner syndrome RecQ helicase in DNA replication. DNA Repair 7: 1776-1786.
175. Smith KN, Singh AM, Dalton S. 2010. Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell 7: 343-354.
176. Squatrito M, Gorrini C, Amati B. 2006. Tip60 in DNA damage response and growth control: Many tricks in one HAT. Trend Cell Biol 16: 433-442.
177. Srinivasan SV, Dominguez-Sola D, Wang LC, Hyrien O, Gautier J. 2013. Cdc45 is a critical effector of myc-dependent DNA replication stress. Cell Rep 3: 1629-1639.
178. Steiger D, Furrer M, Schwinkendorf D, Gallant P. 2008. Max-independent functions of Myc in Drosophila melanogaster. Nat Genet 40: 1084-1091.
179. Steiner P, Philipp A, Lukas J, Godden-Kent D, Pagano M, Mittnacht S, Bartek J, Eilers M. 1995. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. EMBO J 14: 4814-4826.
180. Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT, Stebbings LA, Leroy C, Edkins S, Mudie LJ, et al. 2009. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462: 1005-1010.
181. Studzinski GP, Brelvi ZS, Feldman SC, Watt RA. 1986. Participation of c-myc protein in DNA synthesis of human cells. Science 234: 467-470.
182. Sun Y, Jiang X, Chen S, Fernandes N, Price BD. 2005. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc Natl Acad Sci 102: 13182-13187.
183. Swarnalatha M, Singh AK, Kumar V. 2012. The epigenetic control of E-box and Myc-dependent chromatin modifications regulate the licensing of lamin B2 origin during cell cycle. Nucleic Acids Res 40: 9021-9035.
184. Takayama M, Taira T, Iguchi-Ariga SM, Ariga H. 2000a. CDC6 interacts with c-Myc to inhibit E-box-dependent transcription by abrogating c-Myc/Max complex. FEBS Lett 477: 43-48.
185. Takayama MA, Taira T, Tamai K, Iguchi-Ariga SM, Ariga H. 2000b. ORC1 interacts with c-Myc to inhibit E-box-dependent transcription by abrogating c-Myc-SNF5/INI1 interaction. Genes Cells 5: 481-490.
186. Tanaka S, Umemori T, Hirai K, Muramatsu S, Kamimura Y, Araki H. 2007. CDK-dependent phosphorylation of Sld2 and Sld3 initiates DNA replication in budding yeast. Nature 445: 328-332.
187. Tanaka S, Nakato R, Katou Y, Shirahige K, Araki H. 2011. Origin association of Sld3, Sld7, and Cdc45 proteins is a key step for determination of origin-firing timing. Curr Biol 21: 2055-2063.
188. Tao L, Dong Z, Leffak M, Zannis-Hadjopoulos M, Price G. 2000. Major DNA replication initiation sites in the c-myc locus in human cells. J Cell Biochem 78: 442-457.
189. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, et al. 2002. The b-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250.
190. Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B. 1996. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J 15: 6595-6604.
191. Wang Q, Zhang H, Kajino K, Greene MI. 1998. BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. Oncogene 17: 1939-1948.
192. Waters CM, Littlewood TD, Hancock DC, Moore JP, Evan GI. 1991. c-myc protein expression in untransformed fibroblasts. Oncogene 6: 797-805.
193. Wiese KE, Walz S, von Eyss B, Wolf E, Athineos D, Sansom O, Eilers M. 2013. The role of MIZ-1 in Myc-dependent tumorigenesis. Cold Spring Harb Perspect Med 3: a014290.
194. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, Pasche AC, Knabenhans C, Macdonald HR, Trumpp A. 2004. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 18: 2747-2763.
195. Wong PG, Winter SL, Zaika E, Cao TV, Oguz U, Koomen JM, Hamlin JL, Alexandrow MG. 2011. Cdc45 limits replicon usage from a low density of preRCs in mammalian cells. PloS ONE 6: e17533.
196. Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V, Eilers M, Leon J, Larsson LG. 2003. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22: 351-360.
197. Yabuuchi H, Yamada Y, Uchida T, Sunathvanichkul T, Nakagawa T, Masukata H. 2006. Ordered assembly of Sld3, GINS and Cdc45 is distinctly regulated by DDK and CDK for activation of replication origins. EMBO J 25: 4663-4674.
198. Yamazaki S, Ishii A, Kanoh Y, Oda M, Nishito Y, Masai H. 2012. Rif1 regulates the replication timing domains on the human genome. EMBO J 31: 3667-3677.
199. Yang J, Sung E, Donlin-Asp PG, Corces VG. 2013. A subset of Drosophila Myc sites remain associated with mitotic chromosomes colocalized with insulator proteins. Nat Commun 4: 1464.
200. You Z, Harvey K, Kong L, Newport J. 2002. Xic1 degradation in Xenopus egg extracts is coupled to initiation of DNA replication. Genes Dev 16: 1182-1194.
201. Yu Q, Sicinski P. 2004. Mammalian cell cycles without cyclin E-CDK2. Cell Cycle 3: 292-295.
202. Zhuang D, Mannava S, Grachtchouk V, Tang WH, Patil S, Wawrzyniak JA, Berman AE, Giordano TJ, Prochownik EV, Soengas MS, et al. 2008. C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene 27: 6623-6634.